Ipsen Completes Acquisition
of Clementia

A shared and strengthened commitment to patients with rare diseases

Learn more

Latest Updates

Ipsen group

What we do

Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology, neuroscience and rare diseases.

Careers at Ipsen

Ipsen offers exciting opportunities that will challenge your abilities , expand your skills and reward your contribution in a positive atmosphere of personal and professional development.

Search Ipsen positions

Research & Development

R&D

Commitment

Ipsen’s commitment to research & development is our bold promise to patients to launch at least one new drug or meaningful new indication every year.  We will secure our future by building a pipeline of innovative medicines.

 

Read more

Research & Development

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2019
IPN
-0.37% 109.10€
3:29pm   05/19/2019